Intracellular tools to study specific misfolded protein variants in human disease
Intracellular tools to study specific misfolded protein variants in human disease
批准号:
8307797
负责人:
MICHAEL R SIERKS
金额:
$15.34万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31
关键词:
AddressAlzheimer&aposs DiseaseAmino AcidsAmyloid beta-ProteinAmyotrophic Lateral SclerosisAnkyrin RepeatAntigen TargetingApoptosisBindingBinding ProteinsCell Culture TechniquesCell Differentiation processCell LineCell physiologyCell secretionCellsClear CellCytosolDevelopmentDiabetes MellitusDiagnosisDiseaseDisease ProgressionEngineeringEnvironmentEquus caballusEventExcisionFunctional disorderGene ExpressionGenesGenomicsGoalsHealthHumanHuntington DiseaseImmunoglobulin FragmentsIn SituIndividualLeadLibrariesLocationLysosomesMalignant NeoplasmsMammalian CellMethodsMolecular ChaperonesMolecular ConformationMorphologyNeurodegenerative DisordersNuclearParkinson DiseasePathway interactionsPhage DisplayPrionsProcessProteinsProteomicsRNARNA InterferenceRandomizedReagentRecombinant AntibodyRecombinant ProteinsResearchRoleScientistSignal PathwaySignal TransductionSiteSmall Interfering RNAStem cellsSuperoxide DismutaseTechniquesTestingTherapeuticToxic effectVariantViral ProteinsVirus Diseasesalpha synucleinbasebrain tissuedesignfluorophorehuman Huntingtin proteinhuman diseaseimprovedislet amyloid polypeptidemulticatalytic endopeptidase complexnanobodiesnew technologynovelprion-basedprotein complexprotein degradationprotein foldingprotein misfoldingprotein misfolding and misprocessingprotein misprocessingstem cell differentiationtau Proteinstherapeutic proteintooltraffickingtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Intracellular misfolding or misprocessing of proteins is a critical problem in numerous human diseases including neurodegenerative disorders, diabetes and cancer. The ability to specifically target and manipulate individual protein variants in situ would be a powerful tool in treating these diseases. Inhibitory RNA techniques have revolutionized cell studies, providing the ability to selectively inhibit expression of single genes. Many diseases and cellular processes however result from aberrant protein folding or processing, or from formation of protein complexes, events which cannot be controlled by RNAi. A powerful complementary approach to RNAi techniques would be the ability to selectively target and manipulate a misfolded, misprocessed or complexed protein form intracellularly. In this proposal we will develop reagents that can bind specific protein variants using robust intracellular protein frameworks. Different tags can be added to target specific cell locations and pathways including proteasomes and lysosomes for protein degradation, endosomal targeting for cell internalization, and cell secretion for protein removal. A variety of very exciting applications can be addressed including: 1) targeting misfolded and misprocessed proteins involved in human health problems including neurodegenerative diseases, diabetes and cancer, 2) targeting cell signaling pathways to control apoptosis in diseased cells or differentiation in stem cells, 3) developing chaperone-like reagents that can promote correct protein folding in situ, and 4) targeting viral proteins involved in replication or assembly to provide a means to control viral infection especially in brain tissue. The overall goal of this project is to develop reagents that can be readily modified to intracellularly bind a selected target protein variant and manipulate that target in a predictable manner to achieve a desired result. This ability to manipulate specific intracellular targets can have profound impact on numerous health problems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Purification and Characterization of a toxic AD associated intracellularly generated amyloid beta fragment
-
批准号:10511148
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2022
-
负责人:MICHAEL R SIERKS
-
依托单位:
Protein variants as blood based biomarkers for diagnosing and staging AD
-
批准号:9977069
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2016
-
负责人:MICHAEL R SIERKS
-
依托单位:
Protein variants as blood based biomarkers for diagnosing and staging AD
-
批准号:9334047
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2016
-
负责人:MICHAEL R SIERKS
-
依托单位:
Nanobodies selective for oligomeric Tau species isolated from AD brain
-
批准号:8633097
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2013
-
负责人:MICHAEL R SIERKS
-
依托单位:
Nanobodies selective for oligomeric Tau species isolated from AD brain
-
批准号:8741902
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2013
-
负责人:MICHAEL R SIERKS
-
依托单位:
Developing Diagnostic Nanobodies Against Aggregated TDP-43 Species
-
批准号:8386058
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2012
-
负责人:MICHAEL R SIERKS
-
依托单位:
Developing Diagnostic Nanobodies Against Aggregated TDP-43 Species
-
批准号:8517544
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2012
-
负责人:MICHAEL R SIERKS
-
依托单位:
Intracellular tools to study specific misfolded protein variants in human disease
-
批准号:8191309
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2011
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6092779
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6372479
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6631468
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6509737
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6685537
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位: